Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.01 CAD | 0.00% | +9.12% | +171.82% |
04-22 | HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target | MT |
04-01 | Cardiol Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+171.82% | 150M | |
+29.25% | 48.16B | |
-0.70% | 41.73B | |
+42.95% | 41.03B | |
-5.31% | 28.77B | |
+10.14% | 25.59B | |
-22.59% | 18.96B | |
+9.06% | 12.92B | |
+28.69% | 12.03B | |
-2.30% | 11.77B |
- Stock Market
- Equities
- CRDL Stock
- News Cardiol Therapeutics Inc.
- Canaccord Genuity Adjusts Price Target on Cardiol Therapeutics to $6 From $5, Maintains Buy Rating